Execution of manufacturing contract to manufacture nutraceutical and food products as per agreed specifications and quality standards, to facilitate marketing, distribution and sale of such products.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sampre Nutritions has signed a 3-year manufacturing agreement (dated 16 August 2025) with Tolaram Wellness Ltd., a Nigeria-based company, to exclusively manufacture nutraceutical and food products as per agreed specifications. The deal is expected to generate about INR 10 crores of business annually, totaling roughly INR 30 crores over the contract period. Tolaram will handle marketing, distribution and sale, while Sampre will manufacture and supply. Payment terms include a 50% advance and the balance on dispatch, with Tolaram bearing transportation costs. The parties are unrelated, and no shareholding or related-party issues are involved.
This is a meaningful revenue addition for a small-cap company and could materially boost top-line growth over the next three years, likely supporting the stock price positively if execution stays on track. Investors should monitor quarterly revenue from Tolaram and any disclosures about amendments or termination.